MEK inhibitor resistance mechanisms and recent developments in combination trials
E Kun, YTM Tsang, CW Ng, DM Gershenson… - Cancer treatment …, 2021 - Elsevier
… evade MEK inhibition, and this often involves a re-wiring of the MAPK pathway to reactivate
… by which they can promote cell signaling, and reactivation of RTKs following MEK inhibition …
… by which they can promote cell signaling, and reactivation of RTKs following MEK inhibition …
SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors
H Lu, C Liu, R Velazquez, H Wang, LM Dunkl… - Molecular cancer …, 2019 - AACR
… pathway reactivation in a large panel (n = 34) of KRAS-mutant cell lines, by measuring the
reduction of phospho-MEK … We also found that combining SHP2 and MEK inhibitors led to …
reduction of phospho-MEK … We also found that combining SHP2 and MEK inhibitors led to …
Targeting alterations in the RAF–MEK pathway
R Yaeger, RB Corcoran - Cancer discovery, 2019 - AACR
… However, incomplete pathway suppression or pathway reactivation is a major issue …
combined RAF and MEK inhibitors, as MEK inhibition can suppress the resultant ERK reactivation. …
combined RAF and MEK inhibitors, as MEK inhibition can suppress the resultant ERK reactivation. …
[PDF][PDF] A systematic analysis of signaling reactivation and drug resistance
… We show that no combination of feedbacks coming from the pathway … Combining two RAF
inhibitors blocks ERK pathway reactivation more effectively than combining RAF and MEK …
inhibitors blocks ERK pathway reactivation more effectively than combining RAF and MEK …
[HTML][HTML] Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy
Y Li, Q Dong, Y Cui - Cancer Biology & Medicine, 2019 - ncbi.nlm.nih.gov
… Second, the cotargeting of MEK and resistance pathways by combining MEKi with partner
… In summary, the reactivation of the PI3K-AKT-mTOR pathway and its complex crosstalk with …
… In summary, the reactivation of the PI3K-AKT-mTOR pathway and its complex crosstalk with …
[PDF][PDF] Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma
… on the BRAF/MEK/ERK pathway.Combined BRAF inhibitor (BRAFi) and MEK inhibitor (MEKi) …
ERK pathway reactivation has also been observed in melanoma mouse models12 and …
ERK pathway reactivation has also been observed in melanoma mouse models12 and …
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
R Tripathi, Z Liu, A Jain, A Lyon, C Meeks… - Nature …, 2020 - nature.com
… BRAF-independent activation of MEK, combining BRAF and MEK inhibitors (MEKi; eg … of
ERK-dependent signaling pathways since ERK reactivation is a common resistance mechanism…
ERK-dependent signaling pathways since ERK reactivation is a common resistance mechanism…
Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant …
N Garcia, V Del Pozo, ME Yohe, CM Goodwin… - Molecular cancer …, 2022 - AACR
… We conclude that CRAF reactivation limits the activity of single-agent MEK/ERK inhibitors in
… how combining trametinib with SHP2, FGFR or ERK1/2 inhibitors affected MAPK pathway …
… how combining trametinib with SHP2, FGFR or ERK1/2 inhibitors affected MAPK pathway …
Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation
F Marampon, C Ciccarelli, BM Zani - International journal of molecular …, 2019 - mdpi.com
… However, we reported that radiation combined with MEK/ERK inhibitor treatment in in vivo
… durable targets in MEK inhibition therapy, in which MAPK pathway reactivation occurs early, …
… durable targets in MEK inhibition therapy, in which MAPK pathway reactivation occurs early, …
The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma
M Takemoto, T Tanaka, R Tsuji, Y Togashi… - Biochemical and …, 2021 - Elsevier
… effects of trametinib, a MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As
we … combination group, the tumors gradually grew after seven weeks with MAPK reactivation. …
we … combination group, the tumors gradually grew after seven weeks with MAPK reactivation. …
相关搜索
- mek inhibitors pathway reactivation
- pathway reactivation in ras mutant tumors
- raf mek erk pathway
- tumour responses mek erk pathways
- mapk reactivation dabrafenib trametinib combination therapy
- erk reactivation dual braf mek inhibition
- pharmacological combinations single pathway inhibition
- pathway reactivation in kras mutant tumors
- mek inhibitors in melanoma combined braf
- biological rationale mek erk pathways
- anti-cancer therapy mek erk pathways
- shp2 inhibition pathway reactivation
- combined mek ras mutant tumors
- erk inhibition pathway reactivation
- combined raf mek inhibition
- combination therapy with a mek inhibitor